{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:52:18Z","timestamp":1775137938337,"version":"3.50.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100031715","name":"Ocular Therapeutix, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031715","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40123-026-01357-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:51:58Z","timestamp":1773773518000},"page":"1267-1295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Inflammation and Pain Management with Intracanalicular Dexamethasone Insert: Real-World Applications"],"prefix":"10.1007","volume":"15","author":[{"given":"Eric D.","family":"Donnenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Graff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall E.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savak","family":"Teymoorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srilatha","family":"Vantipalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7595-6267","authenticated-orcid":false,"given":"Aditi","family":"Bauskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"1357_CR1","unstructured":"Healthgrades. The 10 most common surgeries in the U.S. 2021. https:\/\/www.healthgrades.com\/right-care\/tests-and-procedures\/the-10-most-common-surgeries-in-the-u-s. Accessed 18 Dec 2025."},{"issue":"3","key":"1357_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamaophthalmol.2015.5322","volume":"134","author":"CY Kauh","year":"2016","unstructured":"Kauh CY, Blachley TS, Lichter PR, Lee PP, Stein JD. Geographic variation in the rate and timing of cataract surgery among US communities. JAMA Ophthalmol. 2016;134(3):267\u201376.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1357_CR3","volume":"2","author":"EW Gower","year":"2017","unstructured":"Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell PJ. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2(2):CD006364.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1357_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archophthalmol.2012.838","volume":"130","author":"WV Hatch","year":"2012","unstructured":"Hatch WV, Campbell Ede L, Bell CM, El-Defrawy SR, Campbell RJ. Projecting the growth of cataract surgery during the next 25\u00a0years. Arch Ophthalmol. 2012;130(11):1479\u201381.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1357_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.survophthal.2017.07.002","volume":"63","author":"JH Assam","year":"2018","unstructured":"Assam JH, Bernhisel A, Lin A. Intraoperative and postoperative pain in cataract surgery. Surv Ophthalmol. 2018;63(1):75\u201385.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"1357_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/ICO.0000000000001741","volume":"37","author":"R Sajnani","year":"2018","unstructured":"Sajnani R, Raia S, Gibbons A, et al. Epidemiology of persistent postsurgical pain manifesting as dry eye-like symptoms after cataract surgery. Cornea. 2018;37(12):1535\u201341.","journal-title":"Cornea"},{"key":"1357_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0058-3","volume":"15","author":"S Cetinkaya","year":"2015","unstructured":"Cetinkaya S, Mestan E, Acir NO, Cetinkaya YF, Dadaci Z, Yener HI. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015;15:68.","journal-title":"BMC Ophthalmol"},{"key":"1357_CR8","volume-title":"Cataract in the adult eye preferred practice pattern","author":"American Academy of Ophthalmology","year":"2021","unstructured":"American Academy of Ophthalmology. Cataract in the adult eye preferred practice pattern. San Francisco: American Academy of Ophthamology; 2021."},{"key":"1357_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9570.1000572","volume":"7","author":"T Walters","year":"2016","unstructured":"Walters T, Bafna S, Vold S, Wortz G, Harton P, Levenson J. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase\u00a03 studies. J Clin Exp Ophthalmol. 2016;7:1\u201311.","journal-title":"J Clin Exp Ophthalmol"},{"issue":"2","key":"1357_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","volume":"45","author":"SL Tyson","year":"2019","unstructured":"Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase\u00a03 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204\u201312.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"1357_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","volume":"125","author":"E Donnenfeld","year":"2018","unstructured":"Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, phase\u00a0III trial. Ophthalmology. 2018;125(6):799\u2013806.","journal-title":"Ophthalmology"},{"issue":"5","key":"1357_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/aos.13197","volume":"94","author":"S Porela-Tiihonen","year":"2016","unstructured":"Porela-Tiihonen S. Recovery after cataract surgery. Acta Ophthalmol. 2016;94(5):523\u20134.","journal-title":"Acta Ophthalmol"},{"key":"1357_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.17925\/EOR.2012.06.02.98","volume":"6","author":"HS Dua","year":"2012","unstructured":"Dua HS, Attre R. Treatment of post-operative inflammation following cataract surgery\u2014a review. Eur Ophthalmic Rev. 2012;6:98\u2013103.","journal-title":"Eur Ophthalmic Rev"},{"issue":"2","key":"1357_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0161-6420(99)00082-2","volume":"107","author":"HB Dick","year":"2000","unstructured":"Dick HB, Schwenn O, Krummenauer F, Krist R, Pfeiffer N. Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification. Ophthalmology. 2000;107(2):241\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"1357_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/112067210701700104","volume":"17","author":"M Mohammadpour","year":"2007","unstructured":"Mohammadpour M, Jafarinasab MR, Javadi MA. Outcomes of acute postoperative inflammation after cataract surgery. Eur J Ophthalmol. 2007;17(1):20\u20138.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"1357_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ophtha.2015.12.020","volume":"123","author":"T Ianchulev","year":"2016","unstructured":"Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-based cataract surgery: population health outcomes study of more than 21 000 cases in the United States. Ophthalmology. 2016;123(4):723\u20138.","journal-title":"Ophthalmology"},{"issue":"1","key":"1357_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00055735-200002000-00002","volume":"11","author":"AZ McColgin","year":"2000","unstructured":"McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol. 2000;11(1):3\u20136.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"1357_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1213\/01.ANE.0000154206.81132.B9","volume":"100","author":"D Fung","year":"2005","unstructured":"Fung D, Cohen MM, Stewart S, Davies A. What determines patient satisfaction with cataract care under topical local anesthesia and monitored sedation in a community hospital setting? Anesth Analg. 2005;100(6):1644\u201350.","journal-title":"Anesth Analg"},{"key":"1357_CR19","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S165722","volume":"12","author":"TJ Shah","year":"2018","unstructured":"Shah TJ, Conway MD, Peyman GA. Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy. Clin Ophthalmol Auckl. 2018;12:2223\u201335.","journal-title":"Clin Ophthalmol Auckl"},{"key":"1357_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2147\/PRBM.S314214","volume":"14","author":"I Obuchowska","year":"2021","unstructured":"Obuchowska I, Konopinska J. Fear and anxiety associated with cataract surgery under local anesthesia in adults: a systematic review. Psychol Res Behav Manag. 2021;14:781\u201393.","journal-title":"Psychol Res Behav Manag"},{"key":"1357_CR21","volume":"2019","author":"C Shi","year":"2019","unstructured":"Shi C, Yuan J, Zee B. Pain perception of the first eye versus the second eye during phacoemulsification under local anesthesia for patients going through cataract surgery: a systematic review and meta-analysis. J Ophthalmol. 2019;2019:4106893.","journal-title":"J Ophthalmol"},{"issue":"11","key":"1357_CR22","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1001\/jamaophthalmol.2019.3694","volume":"137","author":"AM Kolomeyer","year":"2019","unstructured":"Kolomeyer AM, Yu Y, VanderBeek BL. Association of opioids with incisional ocular surgery. JAMA Ophthalmol. 2019;137(11):1283\u201391.","journal-title":"JAMA Ophthalmol"},{"issue":"Suppl 2","key":"1357_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.13055","volume":"94","author":"S Porela-Tiihonen","year":"2016","unstructured":"Porela-Tiihonen S, Kokki H, Kaarniranta K, Kokki M. Recovery after cataract surgery. Acta Ophthalmol. 2016;94(Suppl 2):1\u201334.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"1357_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ophtha.2019.11.005","volume":"127","author":"S Zafar","year":"2020","unstructured":"Zafar S, Wang P, Schein OD, Srikumaran D, Makary M, Woreta FA. Prescribing patterns and costs associated with postoperative eye drop use in Medicare beneficiaries undergoing cataract surgery. Ophthalmology. 2020;127(5):573\u201381.","journal-title":"Ophthalmology"},{"issue":"5","key":"1357_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/ACI.0b013e32834a9676","volume":"11","author":"N Rosario","year":"2011","unstructured":"Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol. 2011;11(5):471\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1357_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-39-18","volume":"39","author":"M La Rosa","year":"2013","unstructured":"La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr. 2013;39:18.","journal-title":"Ital J Pediatr"},{"key":"1357_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1034\/j.1600-0420.2000.078s230041.x","volume":"230","author":"S Bonini","year":"2000","unstructured":"Bonini S, Ghinelli E. The early and late phase of the ocular allergic reaction. Acta Ophthalmol Scand. 2000;230:41.","journal-title":"Acta Ophthalmol Scand"},{"key":"1357_CR28","unstructured":"American Academy of Ophthalmology. Conjunctivitis preferred practice pattern. San Francisco: AAO; 2018."},{"issue":"2","key":"1357_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361\u20138.","journal-title":"Eye (Lond)"},{"key":"1357_CR30","unstructured":"Alcon Laboratories, Inc. Durezol. Highlights of prescribing information. https:\/\/www.pharma.us.novartis.com\/sites\/www.pharma.us.novartis.com\/files\/durezol.pdf. Accessed 18 Dec 2025."},{"key":"1357_CR31","unstructured":"Alcon Laboratories, Inc. Inveltys prescribing information. Fort Worth. 2023."},{"key":"1357_CR32","unstructured":"Bausch & Lomb, Inc. Lotemax SM. Highlights of prescribing information. Bridgewater. 2023."},{"key":"1357_CR33","unstructured":"Ocular Therapeutix, Inc. Dextenza. Highlights of prescribing information. https:\/\/www.dextenza.com\/wp-content\/uploads\/DEXTENZA-Full-Prescribing-Information.pdf. Accessed 18 Dec 2025."},{"key":"1357_CR34","unstructured":"EyePoint Pharmaceuticals. DEXYCU Highlights of prescribing information. https:\/\/dexycu.com\/wp-content\/uploads\/2019\/01\/DEXYCU-PI-20181220.pdf. Accessed 18 Dec 2025."},{"key":"1357_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4274\/tjo.galenos.2020.11456","volume":"51","author":"BV Villegas","year":"2021","unstructured":"Villegas BV, Benitez-Del-Castillo JM. Current knowledge in allergic conjunctivitis. Turk J Ophthalmol. 2021;51:45\u201354.","journal-title":"Turk J Ophthalmol"},{"issue":"10","key":"1357_CR36","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s12325-013-0059-7","volume":"30","author":"RK Rajpal","year":"2013","unstructured":"Rajpal RK, Fong R, Comstock TL. Loteprednol etabonate ophthalmic gel 0.5% following cataract surgery: integrated analysis of two clinical studies. Adv Ther. 2013;30(10):907\u201323.","journal-title":"Adv Ther"},{"issue":"4","key":"1357_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10792-010-9362-3","volume":"30","author":"MM Hermann","year":"2010","unstructured":"Hermann MM, Ustundag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385\u201390.","journal-title":"Int Ophthalmol"},{"key":"1357_CR38","first-page":"18","volume":"13","author":"C Matossian","year":"2020","unstructured":"Matossian C. Noncompliance with prescribed eyedrop regimens among patients undergoing cataract surgery\u2014prevalence, consequences, and solutions. US Ophthalmic Rev. 2020;13:18\u201322.","journal-title":"US Ophthalmic Rev"},{"issue":"11","key":"1357_CR39","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcrs.2014.02.037","volume":"40","author":"JA An","year":"2014","unstructured":"An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857\u201361.","journal-title":"J Cataract Refract Surg"},{"issue":"Suppl 1","key":"1357_CR40","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/ICU.0000000000000953","volume":"34","author":"J Hovanesian","year":"2023","unstructured":"Hovanesian J, Singh IP, Bauskar A, Vantipalli S, Ozden RG, Goldstein MH. Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy. Curr Opin Ophthalmol. 2023;34(Suppl 1):S1\u201313.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"1357_CR41","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ajo.2011.05.015","volume":"152","author":"AL Hennessy","year":"2011","unstructured":"Hennessy AL, Katz J, Covert D, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152(6):982\u20138.","journal-title":"Am J Ophthalmol"},{"key":"1357_CR42","unstructured":"Cataract Surgeons for Improved Eyecare (CSIE). Analysis of the economic impacts of dropless cataract therapy on Medicare, Medicaid, state governments, and patient costs. http:\/\/stateofreform.com\/wp-content\/uploads\/2015\/11\/CSIE_Dropless_Economic_Study.pdf. Accessed 18 Dec 2025."},{"key":"1357_CR43","doi-asserted-by":"crossref","unstructured":"Hennessy AL, Katz J, Covert D, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152(6):982\u20138.","DOI":"10.1016\/j.ajo.2011.05.015"},{"issue":"11","key":"1357_CR44","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/eye.2013.187","volume":"27","author":"AJ Tatham","year":"2013","unstructured":"Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293\u20138.","journal-title":"Eye (Lond)"},{"issue":"10","key":"1357_CR45","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.4103\/ijo.IJO_3333_20","volume":"69","author":"U Usgaonkar","year":"2021","unstructured":"Usgaonkar U, Zambaulicar V, Shetty A. Subjective and objective assessment of the eye drop instillation technique: a hospital-based cross-sectional study. Indian J Ophthalmol. 2021;69(10):2638\u201342.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"1357_CR46","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1185\/03007995.2013.833898","volume":"29","author":"GF Schwartz","year":"2013","unstructured":"Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515\u201322.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"1357_CR47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5935\/0004-2749.20170058","volume":"80","author":"BF Gomes","year":"2017","unstructured":"Gomes BF, Paredes AF, Madeira N, Moraes HV Jr, Santhiago MR. Assessment of eye drop instillation technique in glaucoma patients. Arq Bras Oftalmol. 2017;80(4):238\u201341.","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"1357_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251699","volume":"16","author":"K Kashiwagi","year":"2021","unstructured":"Kashiwagi K, Matsuda Y, Ito Y, et al. Investigation of visual and physical factors associated with inadequate instillation of eyedrops among patients with glaucoma. PLoS ONE. 2021;16(5):e0251699.","journal-title":"PLoS ONE"},{"issue":"8","key":"1357_CR49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1755-3768.2007.01155.x","volume":"86","author":"TS Dietlein","year":"2008","unstructured":"Dietlein TS, Jordan JF, Luke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008;86(8):856\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"1357_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204363","volume":"13","author":"T Naito","year":"2018","unstructured":"Naito T, Yoshikawa K, Namiguchi K, et al. Comparison of success rates in eye drop instillation between sitting position and supine position. PLoS ONE. 2018;13(9):e0204363.","journal-title":"PLoS ONE"},{"issue":"3","key":"1357_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/IJG.0b013e31820bd2e1","volume":"21","author":"R Gupta","year":"2012","unstructured":"Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21(3):189\u201392.","journal-title":"J Glaucoma"},{"issue":"2","key":"1357_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5005\/jp-journals-10008-1183","volume":"9","author":"G Lazcano-Gomez","year":"2015","unstructured":"Lazcano-Gomez G, Castillejos A, Kahook M, Jimenez-Roman J, Gonzalez-Salinas R. Videographic assessment of glaucoma drop instillation. J Curr Glaucoma Pract. 2015;9(2):47\u201350.","journal-title":"J Curr Glaucoma Pract"},{"issue":"6","key":"1357_CR53","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2009.96","volume":"127","author":"JL Stone","year":"2009","unstructured":"Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009;127(6):732\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1357_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000708","author":"KK Assil","year":"2020","unstructured":"Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2020. https:\/\/doi.org\/10.1097\/ICU.0000000000000708.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"1357_CR55","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/1381612822666161129150628","volume":"23","author":"RL Lindstrom","year":"2017","unstructured":"Lindstrom RL, Galloway MS, Grzybowski A, Liegner JT. Dropless cataract surgery: an overview. Curr Pharm Des. 2017;23(4):558\u201364.","journal-title":"Curr Pharm Des"},{"key":"1357_CR56","doi-asserted-by":"crossref","unstructured":"Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334.","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"1357_CR57","unstructured":"Drugs@FDA: Dextenza. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/208742s007lbl.pdf. Accessed 18 Dec 2025."},{"issue":"9","key":"1357_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/jop.2016.0025","volume":"32","author":"C Blizzard","year":"2016","unstructured":"Blizzard C, Desai A, Driscoll A. Pharmacokinetic studies of sustained-release depot of dexamethasone in beagle dogs. J Ocul Pharmacol Ther. 2016;32(9):595\u2013600.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"1357_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4155\/tde-2020-0010","volume":"11","author":"SL Tyson","year":"2020","unstructured":"Tyson SL, Campbell P, Biggins J, et al. Punctum and canalicular anatomy for hydrogel-based intracanalicular insert technology. Ther Deliv. 2020;11(3):173\u201382.","journal-title":"Ther Deliv"},{"issue":"8","key":"1357_CR60","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1084\/jem.20060336","volume":"203","author":"SM Abraham","year":"2006","unstructured":"Abraham SM, Lawrence T, Kleiman A, et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med. 2006;203(8):1883\u20139.","journal-title":"J Exp Med"},{"issue":"4","key":"1357_CR61","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1172\/JCI112427","volume":"77","author":"JS Goodwin","year":"1986","unstructured":"Goodwin JS, Atluru D, Sierakowski S, Lianos EA. Mechanism of action of glucocorticosteroids. Inhibition of T\u00a0cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. J Clin Invest. 1986;77(4):1244\u201350.","journal-title":"J Clin Invest"},{"issue":"1","key":"1357_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-015-0280-7","volume":"33","author":"A Driscoll","year":"2016","unstructured":"Driscoll A, Blizzard C. Toxicity and pharmacokinetics of sustained-release dexamethasone in beagle dogs. Adv Ther. 2016;33(1):58\u201367.","journal-title":"Adv Ther"},{"key":"1357_CR63","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/OPTH.S307194","volume":"15","author":"C Blizzard","year":"2021","unstructured":"Blizzard C, McLaurin EB, Driscoll A, et al. Plasma pharmacokinetic parameters of dexamethasone following administration of a dexamethasone intracanalicular insert in healthy adults. Clin Ophthalmol (Auckland, NZ). 2021;15:2055\u201361.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"10","key":"1357_CR64","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jcrs.2015.11.005","volume":"41","author":"T Walters","year":"2015","unstructured":"Walters T, Endl M, Elmer TR, Levenson J, Majmudar P, Masket S. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2015;41(10):2049\u201359.","journal-title":"J Cataract Refract Surg"},{"key":"1357_CR65","unstructured":"Tyson S, Bafna S, Berdahl J, Walters T, Metzinger JL, Goldstein MH. Management of ocular inflammation and pain following cataract surgery with DEXTENZA, dexamethasone insert (0.4\u00a0mg): pooled analysis of three phase\u00a03 studies American Society of Cataract and Refractive Surgery; 5\/6\/2019; San Diego, 2019."},{"key":"1357_CR66","unstructured":"Hovanesian J, Donnenfeld E, Berdahl J, et al. Safety and efficacy of a dexamethasone intracanalicular insert (0.4\u00a0mg) for the treatment of ocular pain and inflammation after cataract surgery: pooled analysis of three phase\u00a03 studies European Society for Cataract and Refractive Surgeons; 9\/17\/2019; Paris, 2019."},{"key":"1357_CR67","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2147\/OPTH.S374405","volume":"16","author":"MJ Ibach","year":"2022","unstructured":"Ibach MJ, Zimprich L, Wallin DD, Olevson C, Puls-Boever K, Thompson V. In clinic optometrist insertion of dextenza (dexamethasone ophthalmic insert 0.4\u00a0mg) prior to cataract surgery: the PREPARE study. Clin Ophthalmol (Auckland, NZ). 2022;16:2609\u201315.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR68","doi-asserted-by":"crossref","unstructured":"Lu AQ, Rizk M, O\u2019Rourke T, et al. Safety and efficacy of topical versus intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery. J Cataract Refract Surg. 2022;48(11):1242\u20137.","DOI":"10.1097\/j.jcrs.0000000000000963"},{"key":"1357_CR69","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.2147\/OPTH.S334297","volume":"15","author":"B Saenz","year":"2021","unstructured":"Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD. Evaluation of same-day versus next-day implantation of intracanalicular dexamethasone for the control of postoperative inflammation and pain following cataract surgery. Clin Ophthalmol (Auckland, NZ). 2021;15:4615\u201320.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR70","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.2147\/OPTH.S335764","volume":"15","author":"B Foster","year":"2021","unstructured":"Foster B. Same-day versus next-day dexamethasone intracanalicular insert administration for inflammation and pain control following cataract surgery: a retrospective analysis. Clin Ophthalmol (Auckland, NZ). 2021;15:4091\u20136.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR71","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.2147\/OPTH.S386702","volume":"16","author":"N Fram","year":"2022","unstructured":"Fram N, Alsetri H, Shiler O, Paterno PJ, Cabang J. Retrospective study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation after cataract and corneal surgery. Clin Ophthalmol (Auckland, NZ). 2022;16:4065\u201374.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"3","key":"1357_CR72","first-page":"273","volume":"4","author":"PDG Stephenson","year":"2020","unstructured":"Stephenson PDG. Real-world evaluation of postoperative in-office dexamethasone intracanalicular insert administration for control of postoperative inflammation following cataract surgery. J Clin Ophthalmol. 2020;4(3):273\u20138.","journal-title":"J Clin Ophthalmol"},{"issue":"1","key":"1357_CR73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/j.jcrs.0000000000001022","volume":"49","author":"DM Visco","year":"2023","unstructured":"Visco DM. Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia. J Cataract Refract Surg. 2023;49(1):44\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"1357_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaapos.2020.10.001","volume":"25","author":"RH Trivedi","year":"2021","unstructured":"Trivedi RH, Wilson ME. A sustained-release intracanalicular dexamethasone insert (Dextenza) for pediatric cataract surgery. J AAPOS. 2021;25(1):43\u20135.","journal-title":"J AAPOS"},{"issue":"2","key":"1357_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jop.2016.0154","volume":"33","author":"G Torkildsen","year":"2017","unstructured":"Torkildsen G, Abelson MB, Gomes PJ, McLaurin E, Potts SL, Mah FS. Vehicle-controlled, phase\u00a02 clinical trial of a sustained-release dexamethasone intracanalicular insert in a chronic allergen challenge model. J Ocul Pharmacol Ther. 2017;33(2):79\u201390.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1357_CR76","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2147\/OPTH.S476419","volume":"18","author":"K Kenyon","year":"2024","unstructured":"Kenyon K, McLaurin EB, Silverstein SM, et al. A randomized, multicenter phase\u00a03 clinical trial evaluating intracanalicular dexamethasone insert for the treatment of allergic conjunctivitis. Clin Ophthalmol (Auckland, NZ). 2024;18:2671\u201384.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR77","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ajo.2021.03.017","volume":"229","author":"EB McLaurin","year":"2021","unstructured":"McLaurin EB, Evans D, Repke CS, et al. Phase\u00a03 randomized study of efficacy and safety of a dexamethasone intracanalicular insert in patients with allergic conjunctivitis. Am J Ophthalmol. 2021;229:288\u2013300.","journal-title":"Am J Ophthalmol"},{"key":"1357_CR78","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/OPTH.S440840","volume":"18","author":"S Reich","year":"2024","unstructured":"Reich S, Lopez M, Leff J, Herman J. DEXTENZA versus topical steroid or antihistamine therapy for treatment of allergic conjunctivitis. Clin Ophthalmol (Auckland, NZ). 2024;18:473\u201380.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"9","key":"1357_CR79","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/02713683.2023.2211247","volume":"48","author":"SM Silverstein","year":"2023","unstructured":"Silverstein SM, Sato MA, Meier EJ, et al. Effects of punctal occlusion on ocular itching and conjunctival redness associated with allergic conjunctivitis. Curr Eye Res. 2023;48(9):781\u20137.","journal-title":"Curr Eye Res"},{"key":"1357_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002037","author":"KJ Jackson","year":"2022","unstructured":"Jackson KJ, Akrobetu D, Guduru A, Herndon LW. Intracanalicular dexamethasone insert or topical prednisolone following iStent and Hydrus surgery for glaucoma. J Glaucoma. 2022. https:\/\/doi.org\/10.1097\/IJG.0000000000002037.","journal-title":"J Glaucoma"},{"issue":"9","key":"1357_CR81","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.oret.2023.06.011","volume":"7","author":"JA Ueberroth","year":"2023","unstructured":"Ueberroth JA, Oellers PR, Brown J, Rosenberg KI, Breazzano MP. Intracanalicular dexamethasome insert after retinal surgery: the ADHERE trial. Ophthalmol Retina. 2023;7(9):831\u20133.","journal-title":"Ophthalmol Retina"},{"key":"1357_CR82","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.2147\/OPTH.S330255","volume":"15","author":"IJ Suner","year":"2021","unstructured":"Suner IJ, Peden MC. Dexamethasone sustained-release intracanalicular insert for control of postoperative inflammation after pars plana vitrectomy. Clin Ophthalmol (Auckland, NZ). 2021;15:3859\u201364.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR83","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/OPTH.S466118","volume":"18","author":"H Alsetri","year":"2024","unstructured":"Alsetri H, Fram N, Shiler O. Evaluating a sustained-release dexamethasone insert as adjunctive therapy for inflammation and pain post-corneal transplantation. Clin Ophthalmol (Auckland, NZ). 2024;18:2083\u201391.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"11","key":"1357_CR84","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/j.jcrs.0000000000001279","volume":"49","author":"AS Nattis","year":"2023","unstructured":"Nattis AS, Rosenberg ED, Rasool F. Intracanalicular dexamethasone insert for post-corneal crosslinking inflammation and pain: the LINK study. J Cataract Refract Surg. 2023;49(11):1114\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"1357_CR85","doi-asserted-by":"publisher","DOI":"10.1097\/icl.0000000000001075","author":"MK Rhee","year":"2024","unstructured":"Rhee MK, Zakher M, Najac M, et al. Comparing intracanalicular and topical steroid use in patients undergoing pterygium surgery. Eye Contact Lens. 2024. https:\/\/doi.org\/10.1097\/icl.0000000000001075.","journal-title":"Eye Contact Lens"},{"key":"1357_CR86","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S265311","volume":"14","author":"MD Greenwood","year":"2020","unstructured":"Greenwood MD, Gorham RA, Boever KR. A randomized fellow-eye clinical trial to evaluate patient preference for dexamethasone intracanalicular insert or topical prednisolone acetate for control of postoperative symptoms following bilateral femtosecond laser in site keratomileusis (LASIK). Clin Ophthalmol (Auckland, NZ). 2020;14:2223\u20138.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR87","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.2147\/OPTH.S390815","volume":"16","author":"KJ Jee","year":"2022","unstructured":"Jee KJ, Ling J, Bafna S, Chester T, Augustine J, Wiley WF. Prospective, randomized, fellow eye-controlled study of postoperative pain and inflammation control with an intracanalicular dexamethasone 0.4\u00a0mg ophthalmic insert following small incision lenticule extraction. Clin Ophthalmol (Auckland, NZ). 2022;16:3895\u2013904.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR88","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2147\/OPTH.S311070","volume":"15","author":"J Larsen","year":"2021","unstructured":"Larsen J, Whitt T, Parker B, Swan R. A randomized, controlled, prospective study of the effectiveness and safety of an intracanalicular dexamethasone ophthalmic insert (0.4 mg) for the treatment of post-operative inflammation in patients undergoing refractive lens exchange (RLE). Clin Ophthalmol (Auckland, NZ). 2021;15:2211\u20137.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"1","key":"1357_CR89","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12886-023-02991-5","volume":"23","author":"A Kawahara","year":"2023","unstructured":"Kawahara A. A very early steroid responder after cataract surgery: a case report. BMC Ophthalmol. 2023;23(1):237.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"1357_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcrs.2008.09.024","volume":"35","author":"MS Korenfeld","year":"2009","unstructured":"Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26\u201334.","journal-title":"J Cataract Refract Surg"},{"key":"1357_CR91","unstructured":"Chang RT, Vantipalli S, Akasheh D, et al. Real-world safety analysis of an intracanalicular dexamethasone insert using the IRIS\u00ae Registry (Intelligent Research in Sight). American Society of Cataract and Refractive Surgery Annual Meeting; April 2022; Washington, D.C., 2022."},{"key":"1357_CR92","unstructured":"Xu BY, Mbagwu M, Hatfield M, et al. Real-world safety analysis of 50,000 patients treated with intracanalicular dexamethasone insert using IRIS\u00ae Registry. American Academy of Ophthalmology Annual Meeting; November 2023; San Francisco, 2023."},{"key":"1357_CR93","unstructured":"Spencer P, Blender N, Paolini A, Gurses Ozden R. Safety and effectiveness comparison of hydrogel-based intracanalicular dexamethasone insert placement in the lower versus upper punctum: the SPENCER Study. American Society of Cataract and Refractive Surgery; April 2022; Virtual, 2023."},{"key":"1357_CR94","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/PPA.S126283","volume":"11","author":"JP Gira","year":"2017","unstructured":"Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4\u00a0mg sustained release dexamethasone intracanalicular insert (Dextenza): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487\u201394.","journal-title":"Patient Prefer Adherence"},{"issue":"9","key":"1357_CR95","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3928\/1081597X-20210610-05","volume":"37","author":"MJ Ibach","year":"2021","unstructured":"Ibach MJ, Shafer BM, Wallin DD, Puls-Boever KR, Thompson VM, Berdahl JP. The effectiveness and safety of Dextenza 0.4\u00a0mg for the treatment of postoperative inflammation and pain in patients after photorefractive keratectomy: the RESTORE trial. J Refract Surg. 2021;37(9):590\u20134.","journal-title":"J Refract Surg"},{"key":"1357_CR96","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2147\/OPTH.S359719","volume":"16","author":"DS Dierker","year":"2022","unstructured":"Dierker DS, Hauswirth SG. Thermal pulsation with or without dexamethasone intracanalicular insert for meibomian gland dysfunction: a prospective, masked trial. Clin Ophthalmol (Auckland, NZ). 2022;16:1477\u201385.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR97","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2147\/OPTH.S372440","volume":"16","author":"C Matossian","year":"2022","unstructured":"Matossian C, Stephens JD, Rhee MK, et al. Early real-world physician experience with an intracanalicular dexamethasone insert. Clin Ophthalmol (Auckland, NZ). 2022;16:2429\u201340.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"1357_CR98","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/OPTH.S448973","volume":"18","author":"L Nijm","year":"2024","unstructured":"Nijm L, Matossian C, Rhee MK, et al. Early real-world patient and staff experience with an intracanalicular dexamethasone insert. Clin Ophthalmol (Auckland, NZ). 2024;18:1391\u2013401.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"1","key":"1357_CR99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICU.0000000000000625","volume":"31","author":"NH Shorstein","year":"2020","unstructured":"Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67\u201373.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"1357_CR100","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4103\/ijo.IJO_1186_19","volume":"68","author":"N Bardoloi","year":"2020","unstructured":"Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol. 2020;68(6):1081\u20135.","journal-title":"Indian J Ophthalmol"},{"key":"1357_CR101","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2147\/OPTH.S422502","volume":"17","author":"ED Donnenfeld","year":"2023","unstructured":"Donnenfeld ED, Hovanesian JA, Malik AG, Wong A. A randomized, prospective, observer-masked study comparing dropless treatment regimen using intracanalicular dexamethasone insert, intracameral ketorolac, and intracameral moxifloxacin versus conventional topical therapy to control postoperative pain and inflammation in cataract surgery. Clin Ophthalmol Auckl. 2023;17:2349\u201356.","journal-title":"Clin Ophthalmol Auckl"},{"issue":"3","key":"1357_CR102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","volume":"32","author":"P Barry","year":"2006","unstructured":"Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32(3):407\u201310.","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"1357_CR103","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.jcrs.2013.05.036","volume":"39","author":"K Matsuura","year":"2013","unstructured":"Matsuura K, Miyoshi T, Suto C, Akura J, Inoue Y. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. J Cataract Refract Surg. 2013;39(11):1702\u20136.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"1357_CR104","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcrs.2012.07.031","volume":"39","author":"NH Shorstein","year":"2013","unstructured":"Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013;39(1):8\u201314.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1357_CR105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","volume":"123","author":"A Haripriya","year":"2016","unstructured":"Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123(2):302\u20138.","journal-title":"Ophthalmology"},{"issue":"7","key":"1357_CR106","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/j.jcrs.0000000000000855","volume":"48","author":"ED Donnenfeld","year":"2022","unstructured":"Donnenfeld ED, Mychajlyszyn D, Mychajlyszyn A, Stein R. Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery. J Cataract Refract Surg. 2022;48(7):759\u201364.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"1357_CR107","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334.","journal-title":"Prog Retin Eye Res"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01357-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01357-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01357-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:03:19Z","timestamp":1775134999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01357-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01357-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"1. Lead author: Name: Eric D. Donnenfeld. Disclosure: Eric D. Donnenfeld, declares no relevant affiliations or financial interests with any organization or entity that could be perceived as having a financial stake or conflict related to the subject matter or materials presented in this manuscript. This includes, but is not limited to, employment, consulting roles, honoraria, stock ownership or stock options, expert testimony, grants, patents (issued or pending), or royalty arrangements. 2. Corresponding author: Name: Aditi Bauskar. Disclosure: Aditi Bauskar is an employee of Ocular Therapeutix, Inc. 3. Coauthor: Name: Jordan Graff. Disclosure: Jordan Graff is a consultant with Ocular Therapeutix, Inc. 4. Coauthor: Name: Cathleen McCabe. Disclosure: Cathleen McCabe has been a past speaker and consultant for Ocular Therapeutix, Inc. 5. Coauthor: Name: Kendall E. Donaldson. Disclosure: Kendall E. Donaldson declares no relevant affiliations or financial interests with any organization or entity that could be perceived as having a financial stake or conflict related to the subject matter or materials presented in this manuscript. This includes, but is not limited to, employment, consulting roles, honoraria, stock ownership or stock options, expert testimony, grants, patents (issued or pending), or royalty arrangements. 6. Coauthor: Name: Savak Teymoorian. Disclosure: Savak Teymoorian declares no relevant affiliations or financial interests with any organization or entity that could be perceived as having a financial stake or conflict related to the subject matter or materials presented in this manuscript. This includes, but is not limited to, employment, consulting roles, honoraria, stock ownership or stock options, expert testimony, grants, patents (issued or pending), or royalty arrangements. 7. Coauthor: Name: Trung Tran. Disclosure: Trung Tran is an employee of Ocular Therapeutix, Inc. 8. Coauthor: Name: Srilatha Vantipalli. Disclosure: Srilatha Vantipalli, is an employee of Ocular Therapeutix, Inc. 9. Coauthor: Name: Michael H. Goldstein. Disclosure: Michael H. Goldstein is a former employee of Ocular Therapeutix, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}